Delivery Order SPE2DB20D1109-SPE2DB23FN49F
- Not listed
- This federal contract award is for the delivery of XEOMIN 200 unit vials to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a firm fixed-price delivery order contract with a total ceiling value of $5,242.40, with a period of performance through May 1, 2023. The contract does not have a set-aside designation, indicating open...
- This federal contract award is for the delivery of XEOMIN 200 unit vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $88,072.32 and is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as...
- This federal contract award is for the delivery of XEOMIN 100 unit vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,627.08 and a ceiling value of $1,627.08. The ultimate completion date is January 9, 2025. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of XEOMIN 100 unit vials to the Defense Logistics Agency (DLA). The $7,379.90 Firm Fixed Price Delivery Order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract has no set-aside designation and was awarded under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
- This federal contract award is for the delivery of XEOMIN 100 unit vials, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $31,454.40 Firm Fixed Price Delivery Order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 18, 2024 and was awarded on October 25, 2024. This delivery order is part of a larger $999,999,999...
- This federal contract award is for the delivery of XEOMIN 100 unit vials, awarded by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The $13,559.00 firm fixed-price delivery order contract has a completion date of January 7, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains an Indefinite Delivery...
- This federal contract award is for the delivery of XEOMIN 50 unit vials to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,215.76 and is a Firm Fixed Price Delivery Order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the supply of XEOMIN 50 unit vials to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, and has a ceiling value of $2,850. It is a firm fixed-price delivery order contract with a completion date of July 25, 2024. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of XEOMIN 100 unit vials to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,572.72 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, with a potential value of $999,999,999.00 and...
- This federal contract award is for the delivery of XEOMIN 100 unit vials, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm-fixed price Delivery Order with a ceiling value of $13,106 and an ultimate completion date of November 15, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FN49FDelivery Order
This federal contract award is for the delivery of XEOMIN 200 unit vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,242.40 and is a delivery order contract with a firm fixed price pricing type. The ultimate completion date is March 1, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 2/7/23 |